National Toxicology Program

National Toxicology Program

Nomination Summary for Quinidine (N79313)


Specific Substances: Quinidine

Nomination Date: 09/00/1979

Nominator: NCI

Rationale: Quinidine was nominated based on the interest of the FDA in seeing this drug tested in the NCI bioassay and the lack of carcinogenicity data on this drug. Quinidine is an anti-arrhythmic and cardiotonic drug.

NTP Principles: not specified


Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

Back to Top

CASRN: 56-54-2

Agent Name: Quinidine

NTP is located at the National Institute of Environmental Health Sciences, part of the National Institutes of Health.